Published online Sep 27, 2025. doi: 10.4240/wjgs.v17.i9.109521
Revised: June 4, 2025
Accepted: July 18, 2025
Published online: September 27, 2025
Processing time: 133 Days and 20 Hours
Gallstone (GS), a prevalent biliary disorder, is associated with bile stasis, infection, and cholesterol metabolism. Recent research highlights the potential role of bile microbiota in GS pathogenesis. This is a case control study conducted at Jinshan Hospital between 2022 and 2023.
To investigate the relationship between bile microbiota dysbiosis and GS forma
This is a retrospective analysis conducted at Jinshan Hospital between 2022 and 2023. A total of 40 patients were analyzed, including 25 with GS and 15 with GS-free (GSF). Bile samples from 27 patients were analyzed using 16S rRNA gene sequencing to assess microbial composition.
Significant differences were found in bile acid profiles between GS and GSF groups, with lower microbial diversity in GS patients, indicated by reduced Shan
Dysbiosis, particularly overgrowth of Proteobacteria, may contribute to gallstone formation, while Lactobacillus could play a protective role. Further research is needed to validate these findings.
Core Tip: This retrospective study analyzed bile microbiota composition in 40 patients. Results demonstrated that samples from gallstone patients exhibited significantly reduced overall microbial diversity alongside a striking dominance of Proteobacteria. In contrast, bile samples from gallstone-free individuals showed relative enrichment in health-associated genera, including protective taxa like Lactobacillus. The findings indicate that dysbiosis within the bile microbiome, particularly the overgrowth of Proteobacteria, actively drives gallstone pathogenesis. This suggests that modulating the bile microbiota represents a promising novel therapeutic avenue for gallstone prevention or treatment through targeted interventions.